Detalhe da pesquisa
1.
Triplet combination of BRAF, MEK and PD-1/PD-L1 blockade in melanoma: the more the better?
Curr Opin Oncol
; 33(2): 133-138, 2021 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33399314
2.
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice.
J Transl Med
; 17(1): 376, 2019 11 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31730009
3.
Immunotherapy in metastatic melanoma: a novel scenario of new toxicities and their management.
Melanoma Manag
; 6(4): MMT30, 2019 Nov 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31871619
4.
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma.
Melanoma Res
; 29(5): 510-515, 2019 10.
Artigo
Inglês
| MEDLINE | ID: mdl-30702508
5.
New Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal Injury.
Front Pharmacol
; 8: 354, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28642709
6.
Axitinib after Sunitinib in Metastatic Renal Cancer: Preliminary Results from Italian "Real-World" SAX Study.
Front Pharmacol
; 7: 331, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27733829